EAM
ORIAW

Exos Asset Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Exos Asset Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,000
Closed -$10K – 429
2021
Q3 		$10K Buy
+11,000
New +$14.3K 0.01% 417

Other funds holding ORIAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Exos Asset Management's ORIAW Position: Q4 2021 in Review

Exos Asset Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q4 2021, closing a stake of 11,000 shares — an estimated $10K sold.

Exos Asset Management first reported a position in ORIAW in Q3 2021 and held it in 1 quarter. The position peaked at $10K in Q3 2021. 26 funds tracked by Wall St. Rank hold ORIAW as of Q4 2021.

  • Exos Asset Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q4 2021 after selling out during the quarter.
  • Exos Asset Management sold 11,000 Orion Biotech Opportunities Corp. Warrant shares in Q4 2021, an estimated $10K.
  • Exos Asset Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 1 quarter.
  • Exos Asset Management's Orion Biotech Opportunities Corp. Warrant position peaked at $10K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q4 2021.

Based on Exos Asset Management's 13F filing for Q4 2021, filed 14 Mar 2022.